[HBV and HCV infections among selected group of patients and staff members in the prospective study].
The aim of the study was the clinical and epidemiological evaluation of HBV and HCV infections among 96 patients with chronic renal failure entering dialysis programme, 31 patients with insulin-dependent diabetes and among staff members of Dialysis Unit (29 persons) and Department of Infectious Diseases (54 persons). In the group of haemodialyzed patients we have performed immuno-serological examinations every three months in the period of 18 months. During our study we have not observed any new seroconversion to anti-HCV. Among 66 HBsAg-negative patients 7 (10.6%) of them became HBsAg- and HBeAg-positive despite of active vaccination.